Vaccination against diseases associated with herpesvirus infections in animals: a review.

This research explores the development and application of herpesvirus vaccines in domestic animals. It primarily focuses on viruses causing cytolytic, not oncogenic, infections, and discusses the challenges and successes of both live-modified and inactivated vaccines.

Herpesvirus Infections in Animals

• The paper investigates herpesvirus infections in domestic animals, paying particular attention to the ones causing cytolytic infections, rather than oncogenic infections. Cytolytic infections result in the destruction of the host cell, while oncogenic infections can cause tumors.
• The main infections discussed in this study are Aujeszky’s disease (also known as pseudorabies), infectious bovine rhinotracheitis (IBR), and equine rhinopneumonitis (which can cause equine abortion and is referred to as EHV-1).
• Other infections mentioned include feline viral rhinotracheitis and malignant catarrhal fever of cattle, indicating a range of animals and herpesvirus related conditions that affect them.

Vaccine Development and Use

• Both live-modified and inactivated vaccines are widely used or under development for Aujeszky’s disease, IBR, and EHV-1. Live-modified vaccines are active viruses that have been altered, making them ineffective in causing disease whereas inactivated vaccines contain virus particles, bacteria, or other pathogens that have been killed.
• According to the article, live vaccines are generally successful in specific circumstances, but they also present notable drawbacks. The issues relate to safety or immunogenicity for the individual animal or controlling and eliminating the viruses from whole populations.
• Inactivated vaccines still pose challenges in both preparation and use, and these types of vaccines also experience many of the epidemiological criticisms directed towards modified live vaccines.

Challenges and Future Directions

• The research paper illustrates that while significant advancements have been made in the development and use of vaccines against herpesvirus infections in animals, numerous challenges remain. These include issues of safety and immunogenicity for live-modified vaccines, and preparation and usability issues for inactivated vaccines.
• The study suggests that further research and development is needed to address these issues, as these diseases not only impact the health of individual animals, but can also affect entire animal populations.